After decades of failures, researchers have renewed hopes for an effective HIV vaccine
nbcnews.com/health/health-news/decades-failures-researchers-renewed-hopes-effective-hiv-vaccine-rcna141626
Fight against HIV receives boost with Sh7bn funding: Scientists will draw on lessons learned from the previous seven attempts to develop a HIV vaccine.
nation.africa/kenya/health/fight-against-hiv-receives-boost-with-sh7bn-funding-4544568
HIV vaccine breakthrough after scientists find virus ‘latch’: US team uses ultra-strong x-ray to spot protein movement that leads to infection of cells
thetimes.co.uk/article/hiv-vaccine-breakthrough-after-scientists-find-virus-latch-mj933gs7k
Paid articlePaid
Tiny HIV Surface Movement Unveils Promising Clue for AIDS Vaccine Development: If scientists manage to impede this swift movement in the envelope glycoprotein ...
techtimes.com/articles/301303/20240202/tiny-hiv-surface-movement-unveils-promising-clue-aids-vaccine-development.htm
DNA vaccination induces sustained virus-specific CD8+ T cell immunity in AIDS monkey model
medicalxpress.com/news/2024-02-dna-vaccination-sustained-virus-specific.html
HIV: Broadly neutralizing antibodies protect macaques from infection: Bethesda/Maryland - US researchers protected macaques from infection with the simian by ...
aerzteblatt.de/nachrichten/148761/HIV-Breitneutralisierende-Antikoerper-schuetzen-Makaken-vor-einer-Infektion
HIV antibodies protect animals in proof-of-concept study: Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in ...
medicalxpress.com/news/2024-01-hiv-antibodies-animals-proof-concept.html
HIV vaccine: rethinking required?: After 40 years of research, there is still no vaccine against HIV. A research group from Innsbruck is investigating a new ...
ptaheute.de/aktuelles/2024/01/16/hiv-impfstoff-umdenken-gefragt
HIV vaccine trial dubbed ‘last roll of the dice’ halted over poor results: An HIV vaccine trial dubbed this decade’s “last roll of the dice” has stopped ...
cnn.com/2023/12/09/health/hiv-vaccine-trial-halted-intl/
OPINION: Let's elevate women's leadership in health, a key driver in the triumph over HIV/Aidsow.ly/nTzL50QkyZQ
South Africa: Africa's First HIV Vaccine Trial Fails: An experimental HIV vaccine trial conducted in South Africa, Tanzania, and Uganda was prematurely ...
allafrica.com/stories/202312080382.html
Trial of groundbreaking HIV vaccine halted in Africa: Trial of groundbreaking HIV vaccine halted in Africa
wionews.com/world/trial-of-groundbreaking-hiv-vaccine-halted-in-africa-667491
Virologists making progress in fight against HIV/AIDS: Though slow, research into treating AIDS has been producing ever more effective drugs.
dw.com/en/virologists-making-progress-in-fight-against-hiv-aids/a-67612090
HIV vaccine trial in Africa halted after disappointing initial results : African-led trial ended a year early as researchers conclude there is ‘little or no ...
theguardian.com/global-development/2023/dec/07/prepvacc-hiv-trial-africa-halted-after-disappointing-initial-results-for-combination-vaccine
Another step toward the HIV-1 vaccine: Dynamics of neutralizing antibodies: An international team has for the first time researched the longevity of neutralizing ...
medicalxpress.com/news/2023-11-hiv-vaccine-dynamics-neutralizing-antibodies.html
President Museveni challenges local scientists to fast-track HIV/AIDS vaccine development
newvision.co.ug/articledetails/NV_173645
Scientists to benefit from Shs166b for HIV vaccine discovery: Dr Betty Mwesigwa, the deputy executive director of MUWRP, said the project will run for five years
monitor.co.ug/uganda/news/national/scientists-to-benefit-from-shs166b-for-hiv-vaccine-discovery-4405006
Leaders of two Ugandan research institutions (Joint Clinical Research Center and Makerere University Walter Reed Project) said they would benefit from the $45 ... Show more
The future of the Nobel Prize-winning messenger RNA technology: Scientists explore the potential of a technique that enabled the rapid development of the first ...
english.elpais.com/health/2023-10-03/the-future-of-the-nobel-prize-winning-messenger-rna-technology.html
Africa Scientists Funded by US Seek HIV Vaccine as Lawmakers Debate PEPFAR: South Africa’s Medical Research Council is teaming up with scientists from eight ...
bloomberg.com/news/articles/2023-10-03/africa-scientists-funded-by-us-seek-hiv-vaccine-as-lawmakers-debate-pepfar
South Africa and the US are to start testing a new preventative HIV vaccine and have begun enrolling participants to take part in a clinical trial. Show more
Quick Glance: Guinea Junta Leader Criticizes the West
- Population of southern white rhinoceroses increases for the first time since 2012
- African Parks plans to release 2,000 rhinoceroses after acquiring the largest private breeding facility
- South Africa to clear criminal records from Covid lockdown
- Gloria Orwoba faces trouble with colleagues again
A trial is underway that could be ‘the last roll of the dice’ for an HIV vaccine this decade
cnn.com/2023/08/28/health/prepvacc-hiv-vaccine-trial-spc-scn-intl/
We probably all know someone who has or has had tuberculosis — we just don’t know it
dailymaverick.co.za/article/2023-09-11-we-probably-all-know-someone-who-has-or-has-had-tuberculosis-we-just-dont-know-it/
Corona pioneer Katinger in an interview: "Don't need a second pandemic".: Polymun develops drugs and manufactures new technologies. Biggest success so far: ...
noen.at/klosterneuburg/polymun-klosterneuburg-corona-pionier-katinger-im-interview-brauche-keine-zweite-pandemie-385441536
Quick Glance: Corona Pioneer Katinger Interview: No Second Pandemic
- Dietmar Katinger, CEO of Polymun in Klosterneuburg, played a crucial role in the peak of the Corona pandemic.
- HIV research is a focus in Klosterneuburg, where Polymun has been active since its inception.
- Polymun does not prioritize specific areas but works in various fields.
- Katinger does not have a grand plan for the company's future in ten years.
Vancouver-based Absci partners with Caltech on HIV vaccine research: Vancouver’s resident AI-powered drug generation company Absci announced Thursday that it’s ...
columbian.com/news/2023/aug/11/vancouver-based-absci-partners-with-caltech-on-hiv-vaccine-research/
Glenda Gray, the tiny yellow elephant and the search for lifesaving vaccines: As Professor Glenda Gray sees out the final months of her term at the SA Medical ...
dailymaverick.co.za/article/2023-08-09-glenda-gray-the-elephant-and-the-search-for-lifesaving-vaccines/
Virology institute plans state-of-the-art platform for public health, research - Healthwise
healthwise.punchng.com/virology-institute-plans-state-of-the-art-platform-for-public-health-research/
Institute to unveil platform for health research: The Chief Executive Officer of the Institute of Human Virology, Nigeria, Dr Patrick Dakum has said that the ...
punchng.com/institute-to-unveil-platform-for-health-research/
HEALTHCARE: Six HIV vaccines in research and development in the US, Rwanda, South Africa and Kenya
dailymaverick.co.za/article/2023-05-30-six-hiv-vaccines-in-research-and-development-in-the-us-rwanda-south-africa-and-kenya/
Nigeria: Young, Positive and Resilient - Stories of Young People Living With HIV/Aids in Nigeria
allafrica.com/stories/202303160041.html
HIV patient cured after bone marrow transplant in rare case, research shows: He is one of a small handful of people to receive such treatment effectively
torontosun.com/news/world/hiv-patient-cured-after-bone-marrow-transplant-in-rare-case-research-shows
Public officials and advocates join Washington Post Live to examine the ongoing challenges with the HIV epidemic, the groundwork laid by HIV research for ... Show more
Inside Kenya’s deal with global vaccine agency: Kenya is keen on manufacturing vaccines as a way of increasing access and affordability.
nation.africa/kenya/news/inside-kenya-s-deal-with-global-vaccine-agency-4121644
New vaccine platform could ease development, delivery of antigens: To many, EV stands for "electric vehicle." To researchers at Harvard University and ...
phys.org/news/2023-01-vaccine-platform-ease-delivery-antigens.html
Pharmaceutical giant Johnson & Johnson with quarterly figures - this is how the share will continue
boerse-online.de/aktien/pharma-riese-johnson-johnson-mit-quartalszahlen-so-geht-es-mit-der-aktie-weiter-20325152.html
Medicine: Promising HIV vaccine does not protect: Berlin - A particularly promising vaccine candidate against the immune deficiency disease AIDS does not provide ...
mz.de/panorama/aussichtsreicher-hiv-impfstoff-schutzt-nicht-3527238
HIV vaccine: After the J&J flop - hope for BioNTech and Moderna: Vaccines against Corona were developed in record time
deraktionaer.de/artikel/pharma-biotech/hiv-impfstoff-nach-dem-jj-flop-hoffen-auf-biontech-und-moderna-20325065.html
HIV vaccine fails during trial: The only vaccine against Human Immuno Virus undergoing trials has proved ineffective, its manufacturer has announced.
punchng.com/hiv-vaccine-fails-during-trial/
Another HIV vaccine trial fails after large-scale study: The only vaccine against HIV being tested nearing the completion of testing trials has proved ...
punchng.com/another-hiv-vaccine-trial-fails-after-large-scale-study/
Johnson & Johnson HIV Vaccine Doesn't Protect As Hoped: Great expectations were placed on the vaccine candidate, which should protect against infection with the ...
sueddeutsche.de/wissen/hiv-impfstoff-johnson-johnson-1.5735423
J&J to discontinue HIV vaccine trial: Johnson & Johnson (JNJ.N) said on Wednesday that it was pulling the plug on a late-stage global trial of an HIV vaccine ...
reuters.com/business/healthcare-pharmaceuticals/jj-discontinue-hiv-vaccine-trial-2023-01-18/
HIV vaccine proves ineffective: A promising HIV vaccine does not protect, new data show. Great hopes had been placed in the vaccine candidates of the US ...
kleinezeitung.at/lebensart/gesundheit/6240373/Enttaeuschte-Hoffnungen_HIVImpfstoff-erweist-sich-als-nicht-wirksam
HIV research suffers setback as ‘promising’ vaccine halted: It is the second of its kind to fail but researchers say the results, despairing as they may seem ...
nation.africa/kenya/health/hiv-research-suffers-setback-as-promising-vaccine-halted-4091864
💉 Johnson & Johnson said on Wednesday that it was pulling the plug on a late-stage global trial of an #HIV vaccine after the shot was found ineffective at ... Show more
Fight against AIDS: HIV vaccine disappoints in trial: Researchers have been looking for an effective vaccine against HIV for several years ...
spiegel.de/gesundheit/kampf-gegen-aids-hiv-impfstoff-enttaeuscht-in-studie-a-27e701fc-e86e-4bd7-aab6-74a189766e66
Africa: HIV Remains a Leading Killer in Africa Despite Medical Breakthroughs - How to Eliminate It
allafrica.com/stories/202301080041.html
HIV vaccine candidate induces immune response in early clinical trial: ‘An important step forward’
cnn.com/2022/12/01/health/hiv-vaccine-phase-1-study/
Fascinating science stories to help you survive holiday small talk: Share some science news and facts on wildlife, health breakthroughs, and weird history over ...
popsci.com/science/holiday-science-stories/
Dr. Fauci on fighting stigmas on infectious diseases, from AIDS to COVID: According to NIAID director Anthony Fauci and other public health experts ...
popsci.com/health/fauci-retiring-hiv-aids-covid/
HIV tests dropped by one-third during COVID-19 pandemic: CDC: The number of tests increased in late 2020, but not to pre-pandemic levels.
abcnews.go.com/Health/hiv-tests-dropped-covid-19-pandemic-cdc/story
December 1st is World AIDS Day. A day to commemorate the topic of AIDS. Fortunately, you can live quite well with HIV today, if you know about the disease ... Show more
Hanover in October 1992: bombers arrested, Adis vaccine developed: Hanover breathes a sigh of relief: After two heavy bomb attacks in the city center ...
haz.de/lokales/hannover/hannover-im-oktober-1992-bombenleger-verhaftet-adis-impfstoff-entwickelt-K3XF3YK35QLNQYFUUPDMF57CK4.html
Despite setbacks, HIV can be beaten: But doing so will take patience and money
economist.com/science-and-technology/2022/08/02/despite-setbacks-hiv-can-be-beaten
Despite setbacks, HIV can be beaten: But doing so will take patience and money
economist.com/science-and-technology/2022/08/02/despite-setbacks-hiv-can-be-beaten
Emory testing new vaccine to fight HIV: Larry Scott-Walker was six years old when he first heard about HIV. He remembers being fearful of the disease.
ajc.com/news/coronavirus/emory-testing-new-vaccine-to-fight-hiv/EVP7JKHIJFCU7OH433EPEYTOZE/
There’s still no HIV vaccine. The science behind coronavirus shots may help.: The technology used in coronavirus shots is opening a promising avenue of research ...
washingtonpost.com/health/2022/06/01/hiv-vaccine-covid-vaccine/
Monkeypox dilemma: How to warn gay men about risk without fueling hate: As the U.S. confronts its largest-ever monkeypox outbreak, public health authorities ...
washingtonpost.com/health/2022/06/12/monkeypox-warning-gay-men/
For mRNA, Covid Vaccines Are Just the Beginning: With clinical vaccine trials for everything from HIV to Zika, messenger RNA could transform medicine—or widen ...
wired.co.uk/article/for-mrna-vaccines-covid-was-just-the-beginning
How close are we to getting a vaccine for HIV?: A HIV health expert explains how far off the HIV vaccine is and how the Covid vaccine as affected its development ...
metro.co.uk/2022/06/07/how-close-are-we-to-getting-a-vaccine-for-hiv-16717482/
A revolution in HIV vaccine where it’s needed the most: The IAVI-sponsored HIV vaccine trial, IAVI G003, builds on progress in HIV vaccine research.
nation.africa/kenya/blogs-opinion/blogs/a-revolution-in-hiv-vaccine-where-it-s-needed-the-most-3827458
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics